NantHealth Stock Forecast, Price & News

NantHealth (NASDAQ:NH) Frequently Asked Questions

How has NantHealth's stock been impacted by COVID-19 (Coronavirus)?

NantHealth's stock was trading at $1.81 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NH stock has decreased by 39.2% and is now trading at $1.10.
View which stocks have been most impacted by COVID-19.

When is NantHealth's next earnings date?

NantHealth is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for NantHealth.

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) posted its quarterly earnings results on Thursday, November, 4th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. During the same quarter in the prior year, the business earned ($0.08) earnings per share.
View NantHealth's earnings history.

Who are NantHealth's key executives?

NantHealth's management team includes the following people:

• Patrick Soon-Shiong, Chairman & Chief Executive Officer
• Ronald Allen Louks, Chief Operating Officer (LinkedIn Profile)
• Bob Petrou, Chief Financial Officer
• Tiffany Avery, Chief Medical Officer
• Steve Benz, Senior Vice President-Machine Learning & Research

What is Patrick Soon-Shiong's approval rating as NantHealth's CEO?

82 employees have rated NantHealth CEO Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among NantHealth's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of NantHealth's key competitors?

Some companies that are related to NantHealth include ZIX (ZIXI), Mawson Infrastructure Group (MIGI), Ooma (OOMA), Kaleyra (KLR), So-Young International (SY), Brightcove (BCOV), GTY Technology (GTYH), Phunware (PHUN), Castlight Health (CSLT), MariMed (MRMD), IBEX (IBEX), AcuityAds (ATY), Liberty TripAdvisor (LTRPA), Innodata (INOD) and Sphere 3D (ANY).
View all of NH's competitors.

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

Who are NantHealth's major shareholders?

NantHealth's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (1.18%), Geode Capital Management LLC (0.53%), B. Riley Wealth Management Inc. (0.20%), Millennium Management LLC (0.10%) and Morgan Stanley (0.07%). Company insiders that own NantHealth stock include Patrick Soon-Shiong and Ronald Allen Louks.
View institutional ownership trends for NantHealth.

Which major investors are selling NantHealth stock?

NH stock was sold by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, and Morgan Stanley.
View insider buying and selling activity for NantHealth or view top insider-selling stocks.

Which major investors are buying NantHealth stock?

NH stock was purchased by a variety of institutional investors in the last quarter, including B. Riley Wealth Management Inc., Millennium Management LLC, and BlackRock Inc..
View insider buying and selling activity for NantHealth or or view top insider-buying stocks.

How do I buy shares of NantHealth?

Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $1.10.

How much money does NantHealth make?

NantHealth has a market capitalization of $126.99 million and generates $73.17 million in revenue each year. The company earns $-56.33 million in net income (profit) each year or ($0.54) on an earnings per share basis.

How many employees does NantHealth have?

NantHealth employs 354 workers across the globe.

What is NantHealth's official website?

The official website for NantHealth is www.nanthealth.com.

Where are NantHealth's headquarters?

NantHealth is headquartered at 9920 JEFFERSON BLVD, CULVER CITY CA, 90232.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at (310) 883-1300 or via email at [email protected].